Gemcitabine Mechanism of Action Confounds Early Assessment of Treatment Response by 3′-Deoxy-3′-[18F]Fluorothymidine in Preclinical Models of Lung Cancer-Reference-Cited by-同舟云学术

Gemcitabine Mechanism of Action Confounds Early Assessment of Treatment Response by 3′-Deoxy-3′-[18F]Fluorothymidine in Preclinical Models of Lung Cancer

Published:2016-10-26 Issue:24 Volume:76 Page:7096-7105
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Schelhaas Sonja,Held Annelena,Wachsmuth Lydia,Hermann Sven,Honess Davina J.,Heinzmann Kathrin,Smith Donna-Michelle,Griffiths John R.,Faber Cornelius,Jacobs Andreas H.

Funder

European Union Seventh Framework Programme

Deutsche Forschungsgemeinschaft

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combining Scalable Organ Chip Platform with Deep Learning-Based Imaging Analysis for Cancer Therapeutic Screening;2024-06-12

2. Co-delivery of gemcitabine and cisplatin via Poly (L-glutamic acid)-g-methoxy poly (ethylene glycol) micelle to improve the in vivo stability and antitumor effect;Pharmaceutical Research;2021-12

3. Voxel-Based Analysis of the Relation of 3′-Deoxy-3′-[18F]fluorothymidine ([18F]FLT) PET and Diffusion-Weighted (DW) MR Signals in Subcutaneous Tumor Xenografts Does Not Reveal a Direct Spatial Relation of These Two Parameters;Molecular Imaging and Biology;2021-11-09

4. Imaging of Gene and Cell-Based Therapies: Basis and Clinical Trials;Molecular Imaging;2021

5. Inhibition of autophagy flux by sertraline attenuates TRAIL resistance in lung cancer via death receptor 5 upregulation;International Journal of Molecular Medicine;2020-06-05